ライフサイエンスコーパス: numbness

1 d with acute-onset, right-sided weakness and numbness.

2 No partners reported penile numbness.

3 cation, photophobia, visual disturbance, and numbness.

4 d with acute-onset, right-sided weakness and numbness.

5 n-years (206 for hand numbness, 187 for feet numbness, 130 for nocturia, and 127 for urgency).

6 ften reported tingling (29% v 8%; P = .001), numbness (17% v 5%; P = .005), and aching or burning pai

7 computed in 1000 person-years (206 for hand numbness, 187 for feet numbness, 130 for nocturia, and 1

8 e most common symptoms were heaviness (52%), numbness (47%), and tightness (45%).

9 reported less difficulty related to residual numbness and decreased lip sensitivity than those who pe

10 ic patient presented with a 7-day history of numbness and dizziness.

11 effect and significantly lowered the risk of numbness and muscle weakness of the thigh, which is more

12 ncreased functional complaints, particularly numbness and nausea.

13 s after chemotherapy presented with the most numbness and pain and also the most pronounced sensory d

14 Sensory abnormalities such as numbness and paresthesias are often the earliest symptom

15 ing was the most severe symptom, followed by numbness and then pain.

16 Numbness and tingling are more prominent chronic neuropa

17 continued foot discomfort (eg, moderate foot numbness and tingling for 22.1% FLOX v 4.6% FULV).

18 Carpal tunnel syndrome is characterized by numbness and tingling in the thumb and the index, middle

19 Those reporting a numbness and tingling severity score of 3 or greater for

20 Of the sensory neuropathy symptoms, numbness and tingling were more prominent than was shoot

21 nalogue scale (VAS) assessments for "pain," "numbness," and "groin discomfort" on a scale of 0 = best

22 The symptoms of chronic pain, tingling, and numbness are generally attributed to small fiber dysfunc

23 mum and average pain, and their intensity of numbness as well as experience of side effects; the prob

24 fatigue (31.4%), insomnia (23.3%), and local numbness at the site of surgery (22.1%) occurring with g

25 neurological (lightheadedness, headache and numbness), cardiopulmonary (shortness of breath and oede

26 diotherapy group reported severe tingling or numbness compared with 11 (6%) of 170 patients in the ra

27 -1.53 to -0.43) general pain, moderate/high numbness (d, -0.99; 95% CI, -1.69 to -0.29), and moderat

28 lting in injury (n = 2), and 1 case each for numbness, diplopia, and tooth loss during intubation.

29 dyspnea, constipation, thirst, leg swelling, numbness, dry mouth, and balance problems.

30 e events following exposure, and feelings of numbness following exposure are useful predictors of sub

31 well tolerated and reduces the rate of pain/numbness/groin discomfort by 45% relative to sutures wit

32 n reduce the incidence of postoperative pain/numbness/groin discomfort by up to 50% compared with sut

33 abling complications (VAS score >30 for pain/numbness/groin discomfort) at 12 months after surgery.

34 isaster, and those who experienced emotional numbness immediately after the disaster.

35 ingling or weakness in the arms or legs, and numbness in any part of the body correlated with appropr

36 neuropathy (CIPN), characterized by pain and numbness in hands and feet, is a common side effect of c

37 The next day, he experienced numbness in his left arm.

38 In addition, he experiences episodic numbness in his limbs, which started at the age of 37 ye

39 All had numbness in the distribution of neurectomy without compl

40 e mild diplopia, intermittent dizziness, and numbness in the left arm over the course of 3 months.

41 pisode, with headache, reduced movement, and numbness in the left hand.

42 tion of this procedure was mild medial thigh numbness in two patients.

43 enced by 27 patients; 'prickling' or 'asleep numbness' in 20, mild pain in 13 and sensory loss in 23.

44 The most common long-term symptom was numbness involving the upper, inner aspect of the affect

45 7 patients (37%) reported transient earlobe numbness; IVCM revealed transient corneal neuromas in 8

46 A 45-year-old woman noted foot numbness, limb weakness, gait and postural instability,

47 cal responses to the pandemic contributed to numbness, loss of motivation, and self-alienation.

48 tive arm swelling, rate of seroma formation, numbness, loss of sensitivity to light touch and pinpric

49 This "transcriptional numbness" lowers the probability of cell death at early

50 ain, muscle pain, hearing loss, visual loss, numbness of hands or feet were longitudinally assessed a

51 0001) with all symptoms declining except for numbness of hands or feet.

52 zed by ataxia, skeletal muscles weakness and numbness of the extremities in exposed human and laborat

53 rectly identified sudden 1-sided weakness or numbness of the face or a limb as a warning sign compare

54 dy weakness, burning sensation, tingling and numbness of the feet, fatigue, loss of libido, and occas

55 ase of a 72-year old male who presented with numbness of the right hand, progressive weakness in both

56 by burning pain in the ball of the foot and numbness or burning pain that may radiate to the affecte

57 One hundred fifty-three (76.5%) patients had numbness or paresthesias of the medial arm and/or axilla

58 rash, mouth or throat sores, itchy skin, and numbness or tingling in hands or feet) were absent or mi

59 no bowel or bladder issues and no weakness, numbness, or history of trauma.

60 uth, lips, or gums; trouble with eyes; pain, numbness, or tingling of hands or feet; and diarrhea or

61 ry leads to significant morbidity, including numbness, pain, weakness or paralysis.

62 disturbance of the hands and feet including numbness, paraesthesia and chronic pain.

63 opathy with distal sensory symptoms, such as numbness, paresthesia, and dysesthesias (although the au

64 hies are common conditions and can result in numbness, paresthesia, motor deficits, and pain.

65 (Startle, Physiological Arousal, Anger, and Numbness), Prime-MD Patient Health Questionnaire, TWEAK

66 LIHR has a reduced risk of chronic pain and numbness relative to OIHR.

67 s and the subjective experience of cognitive numbness reported by patients.

68 es patients, including limb pain followed by numbness resulting from peripheral nerve damage.

69 , 95% CI = 0.51-0.87, P = 0.003) and chronic numbness (RR = 0.27, 95% CI = 0.12-0.58, P < 0.001) rela

70 Patients with complaints of numbness, tingling, and dysesthesias in the toes and fee

71 ary care physician with a 3-month history of numbness, tingling, and faint violaceous discoloration o

72 greater burden of neurologic symptoms (pain, numbness, tingling, and walking disability) and worse qu

73 Among chronic functional problems, numbness, tinnitus, nausea elicited by reminders of chem

74 r limbs for 3 days, accompanied by ascending numbness to just below his nipples.

75 s and somatosensory dysfunction ranging from numbness to pain.

76 y, politics, or the healthcare organization, numbness toward patients and families, and disorientatio

77 emic or ocular signs and symptoms (headache, numbness, weakness, vertigo, syncope, diplopia, hypotens

78 in rates of hematoma, sialocele, seroma, ear numbness, wound infection, or unplanned return to emerge